We know that chronic obstructive pulmonary disease (COPD) is common and that cigarette smoking is also a risk factor for other important diseases, but how likely is it that a patient with COPD will ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription. So various treatment options have different ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the transcription.

Common comorbidities in all patients with urticaria included allergic rhinitis, allergic asthma, allergic conjunctivitis, atopic dermatitis, Helicobacter pylori infection, and parasitic infection. The ...

Chronic inflammation from uncontrolled type 2 inflammatory diseases can lead to cardiovascular complications, including hypertension and atherosclerosis. Metabolic disorders, such as insulin ...

Living with Crohn’s disease often means managing more than just its typical symptoms. Many people with Crohn’s experience additional health issues, or comorbidities, that affect their overall ...

Autism spectrum disorder (10.9% vs 1.0%; OR, 10.67; 95% CI, 6.35-17.91; P .001) and attention-deficit hyperactivity disorder (13% vs 3.4%; OR, 3.9; 95% CI, 3.80-4.08; P .001) are more prevalent among ...

Cardiovascular diseases and diabetes are some of the most common coexisting conditions in COPD. Shared risk factors and overlapping physiological processes likely contribute to the high rate of ...

Pediatric hidradenitis suppurativa is linked to increased prevalence of obesity, anxiety, and depression, impacting quality of life. A systematic review and meta-analysis identified obesity, acne ...

A new analysis examined the electronic medical records of patients 18 years of age and older hospitalized with RSV. Of 235 patients with RSV, the longest average lengths of stays were observed among ...

GLP-1 receptor agonist (RA) prescribing increased from 0.2 to 6.4 per 1000 deliveries predelivery and from 0.3 to 14.6 per 1000 deliveries postdelivery between 2019 and 2024. Among recipients in 2024, ...